Principal Financial Group Inc Olink Holding Ab (Publ) Transaction History

Principal Financial Group Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$21.87 - $25.59 $148,716 - $174,012	-6,800 Reduced 1.81%	369,628 $9.42 Million
Q1 2024 Apr 29, 2024	BUY	$21.81 - $25.14 $389,046 - $448,447	17,838 Added 4.97%	376,428 $8.85 Million
Q4 2023 Feb 07, 2024	SELL	$14.29 - $25.95 $8.19 Million - $14.9 Million	-573,159 Reduced 61.51%	358,590 $9.02 Million
Q3 2023 Nov 02, 2023	SELL	$14.45 - $20.34 $120,209 - $169,208	-8,319 Reduced 0.88%	931,749 $13.7 Million
Q2 2023 Aug 07, 2023	SELL	$17.13 - $23.74 $14,046 - $19,466	-820 Reduced 0.09%	940,068 $17.6 Million
Q1 2023 May 09, 2023	BUY	$19.34 - $24.11 $5.05 Million - $6.29 Million	260,913 Added 38.37%	940,888 $21.2 Million
Q4 2022 Feb 09, 2023	SELL	$12.64 - $25.52 $204,856 - $413,602	-16,207 Reduced 2.33%	679,975 $17.3 Million
Q3 2022 Nov 09, 2022	BUY	$12.14 - $18.42 $1.82 Million - $2.76 Million	150,089 Added 27.48%	696,182 $8.45 Million
Q2 2022 Aug 10, 2022	BUY	$8.95 - $19.24 $693,517 - $1.49 Million	77,488 Added 16.54%	546,093 $8.3 Million
Q1 2022 May 09, 2022	BUY	$11.33 - $19.3 $14,037 - $23,912	1,239 Added 0.27%	468,605 $8.28 Million
Q4 2021 Feb 09, 2022	BUY	$18.0 - $34.82 $2.89 Million - $5.59 Million	160,623 Added 52.36%	467,366 $8.51 Million
Q3 2021 Nov 09, 2021	BUY	$23.42 - $37.93 $279,377 - $452,466	11,929 Added 4.05%	306,743 $7.44 Million
Q2 2021 Aug 10, 2021	SELL	$26.65 - $39.47 $485,003 - $718,314	-18,199 Reduced 5.81%	294,814 $10.1 Million
Q1 2021 May 24, 2021	BUY	$31.9 - $36.0 $9.99 Million - $11.3 Million	313,013 New	313,013 $11.3 Million

799K

Ticker OLK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 119,098,000
Description
Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.